A guideline for the treatment of dementia in Japan

12Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

Worldwide energetic efforts have provided several clues for the management of Alzheimer's disease and related dementias in elderly people, although the history of dementia treatment is not long. Various pharmacological or non-pharmacological treatments are carried out in daily medical practice, but evidence for the validity of these treatments is limited. In United States and Europe, several pharmacological and a few non-pharmacological treatments have been proven effective and a few drugs are approved by various governments and used in practice. In contrast, only one acetylcholinesterase inhibitor, donepezil has been proven effective and used for patients with mild or moderate Alzheimer's disease in Japan. Anti-hypertensive or anti-platelet therapy has been shown to reduce the incidence or recurrence of stroke, probably preventing vascular dementia. Effectiveness of drugs and types of care awaits to be validated in the light of scientific procedures.

Cite

CITATION STYLE

APA

Nakamura, S. (2004). A guideline for the treatment of dementia in Japan. Internal Medicine, 43(1), 18–29. https://doi.org/10.2169/internalmedicine.43.18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free